Shares of Natco Pharma edged up 1.01% to ₹1,364.90 in early trading today, following the company’s announcement of selling a 14.38-acre land parcel in Telangana for ₹115.57 crore. The transaction includes infrastructure costs and was finalized on November 27, 2024.
The sold property, located at Mekaguda Gram Panchayat in Ranga Reddy District, Telangana, spans 72,358 square yards. Natco Pharma clarified that the land was not being used for any business operations and that the sale will not impact its core activities.
Known for its innovative pharmaceutical research, Natco Pharma operates eight advanced manufacturing facilities across India. The land sale highlights the company’s strategic monetization of non-operational assets, further strengthening its financial position.
This development reflects positive sentiment among investors as the company continues to focus on its core operational strengths.
Disclaimer: The information provided is for informational purposes only and should not be considered financial or investment advice. Stock market investments are subject to market risks. Always conduct your own research or consult a financial advisor before making investment decisions.
